Evidence map›Paper›PMID 19161227›Full record

ArticleDevelopmental dynamics : an official publication of the American Association of Anatomists2009

Ligand-specific function of transforming growth factor beta in epithelial-mesenchymal transition in heart development.

Mohamad Azhar, Raymond B Runyan, Connie Gard, L Philip Sanford, Marian L Miller, Anastasia Andringa, Sharon Pawlowski, Sudarsan Rajan, Thomas Doetschman

Open access · bronzeAbstract read
In one paragraph

Article in Developmental dynamics : an official publication of the American Association of Anatomists, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 117 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Functional Study of PTSMAD4 in the Spermatogenesis of the Swimming CrabInternational journal of molecular sciences · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. TGF-β signaling in health, disease, and therapeutics.Signal transduction and targeted therapy · 2024
    Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Mohamad AzharBIO5 Institute, University of Arizona, Tucson, Arizona, USA. azharm@email.arizona.edu
Raymond B Runyan
Connie Gard
L Philip Sanford
Marian L Miller
Anastasia Andringa
Sharon Pawlowski
Sudarsan Rajan
Thomas Doetschman
University of Arizona · USUniversity of Cincinnati Medical Center · US

Funding

SOUTHWEST ENVIRONMENTAL HEALTH SCIENCES CENTERP30ES006694 · NIEHS · UNIVERSITY OF ARIZONA · PI DEAN BILLHEIMER · 1994 to 2026
$36.7M
Signaling Mechanisms of FGF2-induced CardioprotectionR01HL075633 · NHLBI · UNIVERSITY OF CINCINNATI · PI SCHULTZ, JOEL J · 2004 to 2014
$3.5M
TARGETED MUTATION OF TGF-BETA-1 IN ES CELLSR01HD026471 · NICHD · UNIVERSITY OF CINCINNATI · PI DOETSCHMAN, THOMAS · 1990 to 2005
$1.8M
Roles of FGF2 and TGFbeta in cardiac hypertrophyR01HL070174 · NHLBI · UNIVERSITY OF CINCINNATI · PI DOETSCHMAN, THOMAS · 2002 to 2005
$1.5M
Regulation of EMT During Avian Heart Valve FormationR01HL082851 · NHLBI · UNIVERSITY OF ARIZONA · PI RUNYAN, RAYMOND BRUCE · 2007 to 2010
$1.5M
Regulation of Periostin by TGFbeta and BMP in Heart DevelopmentR01HL092508 · NHLBI · INDIANA UNIVERSITY INDIANAPOLIS · PI CONWAY, SIMON JAMES, DOETSCHMAN, THOMAS · 2009 to 2010
$929k
NHLBI NIH HHS R01 HL070174NHLBI NIH HHS R01 HL075633NHLBI NIH HHS R01 HL082851NHLBI NIH HHS R01 HL092508NICHD NIH HHS R01 HD026471NICHD NIH HHS R01 HD26471NICHD NIH HHS R01 HD82851NIEHS NIH HHS P30 ES006694
6 · The paper itself

Abstract

The ligand specificity of transforming growth factor beta (TGFbeta) in vivo in mouse cardiac cushion epithelial-to-mesenchymal transition (EMT) is poorly understood. To elucidate the function of TGFbeta in cushion EMT, we analyzed Tgfb1(-/-), Tgfb2(-/-), and Tgfb3(-/-) mice between embryonic day (E) 9.5 and E14.5 using both in vitro and in vivo approaches. Atrioventricular (AV) canal collagen gel assays at E9.5 indicated normal EMT in both Tgfb1(-/-) and Tgfb3(-/-) mice. However, analysis of Tgfb2(-/-) AV explants at E9.5 and E10.5 indicated that EMT, but not cushion cell proliferation, was initially delayed but later remained persistent. This was concordant with the observation that Tgfb2(-/-) embryos, and not Tgfb1(-/-) or Tgfb3(-/-) embryos, develop enlarged cushions at E14.5 with elevated levels of well-validated indicators of EMT. Collectively, these data indicate that TGFbeta2, and not TGFbeta1 or TGFbeta3, mediates cardiac cushion EMT by promoting both the initiation and cessation of EMT.

Indexed as

AnimalsCell DifferentiationCell ProliferationEndothelial CellsEpithelial CellsHeartLigandsMesodermMiceMice, KnockoutTransforming Growth Factor betaTransforming Growth Factor beta1Transforming Growth Factor beta2Transforming Growth Factor beta3LigandsTransforming Growth Factor betaTransforming Growth Factor beta1Transforming Growth Factor beta2Transforming Growth Factor beta3

Identifiers

PMID19161227
PMCPMC2805850
OpenAlexW2007343355

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.